The persons with light and moderate forms of COVID-19, who receive treatment at home, can benefit from drugs compensated from the mandatory health insurance funds as of today, December 18, after the infection was put on the list of priority diseases that are frequently met in the family doctor’s practice. The relevant changes to common orders of the Ministry of Health, Labor and Social Protection and the National Health Insurance Company (CNAM) were published in the Official Gazette, IPN reports.

The medicines intended for treating COVID-19 in ambulatory conditions will be prescribed by the family doctor both to medically insured and to medically uninsured persons. These drugs will be fully compensated for children younger than 18 and in the amount of 70% for adults. The citizens can benefit from at least one commercial name of medicine of the compensated ones (21 common international names of medicines).

There will be prescribed drugs for symptomatic treatment, such as antihtrombotics and anticoagulants (acidum acetylsalicylicum, clopidogrelum, sulodexidum), medicines that regulate gastric acid secretion (famotidinum), vasodilatators (pentoxifyllinum) and bronchodilatators (salbutamolum).

In case of fever, antipyretic and anti-inflammatory medicines, such as paracetamolum and ibuprofenum, and also mucolytic and expectorant drugs, such as ambroxolum, acetylcysteinum and carbocisteinum, will be prescribed to children.

About 655 million lei was earmarked in 2020 for compensated drugs. Over 555 million lei of this sum was used in 11 months of the year.

The list of medicines is available from the family doctor and drugstores and at Info CNAM on 0 800 99999 and on the Company’s website.